HRID1746825

反应详情

EQUATION

反应方程式

REACTANTS

反应物

结构：Cc1c(Cl)cc(S(=O)(=O)O)cc1NC(=O)NC[C@H](N)C(=O)O

HCID53374467

未命名化合物

结构：Cc1c(Cl)cc(NC(=O)NC[C@H](N)C(=O)O)cc1S(=O)(=O)O

HCID53374468

未命名化合物

结构：N[C@@H](CNC(=O)Nc1cc(Cl)cc(S(=O)(=O)O)c1O)C(=O)O

HCID53377991

未命名化合物

PRODUCTS

生成物

结构：N[C@@H](CNC(=O)Nc1cccc(S(=O)(=O)O)c1)C(=O)O

HCID88905973

未命名化合物

PROCEDURE

实验过程

Above all, (2S)-2-amino-3-{[(5-chloro-2-hydroxy-3-sulfophenyl)carbamoyl]amino}propanoic acid, (2S)-2-amino-3-{[(3-chloro-4-methyl-5-sulfophenyl)carbamoyl]amino}propanoic acid and (2S)-2-amino-3-{[(3-chloro-2-methyl-5-sulfophenyl)carbamoyl]amino}propanoic acid, or salts thereof, are particularly preferable as a compound that is used as a prophylactic or therapeutic agent for diabetes or obesity of the present invention.